Literature DB >> 28738044

Survivorship Model of Care: Development and Implementation of a Nurse Practitioner-Led Intervention for Patients With Breast Cancer
.

Kathryn E Post1, Beverly Moy1, Catherine Furlani1, Elizabeth Strand1, Jane Flanagan2, Jeffrey M Peppercorn1.   

Abstract

BACKGROUND: Despite a call for action to improve survivorship care, no optimal model of care exists. 
.
OBJECTIVES: To develop and evaluate the feasibility of a nurse practitioner (NP)-led model of care for survivorship visits after initial therapy. 
.
METHODS: Patients received an NP-led survivorship bridge visit (NPSBV) following treatment for early-stage breast cancer. A cross-sectional survey was used to evaluate responses to the NPSBV and patient satisfaction with care. Satisfaction with usual care was evaluated in a comparison of patient groups. Differences were assessed with a chi-square test or Fisher's exact test.
.
FINDINGS: Of 166 surveys, 118 were returned. The NPSBV met feasibility with a high attendance rate and had high acceptability and satisfaction rates. NPSBV patients were more likely to report that their team always cared as much as they did about their health compared to controls. Most patients would recommend the NPSBV to others.

Entities:  

Keywords:  breast cancer; interdisciplinary care model; nurse practitioner; survivorship

Mesh:

Year:  2017        PMID: 28738044     DOI: 10.1188/17.CJON.E99-E105

Source DB:  PubMed          Journal:  Clin J Oncol Nurs        ISSN: 1092-1095            Impact factor:   1.027


  2 in total

1.  Advanced Practice Providers and Survivorship Care: They Can Deliver.

Authors:  Bridgette Thom; Annelies H Boekhout; Stacie Corcoran; Roberto Adsuar; Kevin C Oeffinger; Mary S McCabe
Journal:  J Oncol Pract       Date:  2019-01-07       Impact factor: 3.840

2.  Feasibility, acceptability, and utility of a nurse-led survivorship program for people with metastatic melanoma (MELCARE).

Authors:  Julia Lai-Kwon; Brooke Kelly; Sarah Lane; Rebecca Biviano; Iris Bartula; Frank Brennan; Ingrid Kivikoski; Jake Thompson; Haryana M Dhillon; Alexander Menzies; Georgina V Long
Journal:  Support Care Cancer       Date:  2022-09-22       Impact factor: 3.359

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.